Thursday, September 4, 2014

Bone Marrow Transplantation - Table of Contents alert Volume 49 Issue 9

If you are unable to see the message below, click here to view.
Bone Marrow Transplantation

TABLE OF CONTENTS

Volume 49, Issue 9 (September 2014)

In this issue
Reviews
Original Articles
Letters To The Editor
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
SPECIAL SAVINGS: Latest lab equipment and services

Discover the resource everyone is using!

Before you buy, VISIT MARKETPLACE
 

Reviews

Top

Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future

J M Jaso, S A Wang, J L Jorgensen and P Lin

Bone Marrow Transplant 2014 49: 1129-1138; advance online publication, May 19, 2014; 10.1038/bmt.2014.99

Abstract | Full Text

New frontiers in pediatric Allo-SCT

J M Talano, M A Pulsipher, H J Symons, O Militano, E B Shereck, R H Giller, L Hancock, E Morris and M S Cairo

Bone Marrow Transplant 2014 49: 1139-1145; advance online publication, May 12, 2014; 10.1038/bmt.2014.89

Abstract | Full Text

Original Articles

Top

CHRONIC LEUKEMIA

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis

H Jiang, L-P Xu, D-H Liu, K-Y Liu, S-S Chen, B Jiang, Q Jiang, H Chen, Y-H Chen, W Han, X-H Zhang, Y Wang, J-Z Wang, F-R Wang, Y-Z Qin, Y-Y Lai and X-J Huang

Bone Marrow Transplant 2014 49: 1146-1154; advance online publication, July 21, 2014; 10.1038/bmt.2014.146

Abstract | Full Text

GRAFT SOURCE

Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation

K Nakatani, K Imai, M Shigeno, H Sato, M Tezuka, T Okawa, N Mitsuiki, T Isoda, D Tomizawa, M Takagi, M Nagasawa, M Kajiwara, M Yamamoto, A Arai, O Miura, C Kamae, N Nakagawa, K Honma, S Nonoyama, S Mizutani and T Morio

Bone Marrow Transplant 2014 49: 1155-1161; advance online publication, June 30, 2014; 10.1038/bmt.2014.123

Abstract | Full Text

CONDITIONING

Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning

M Shanavas, H A Messner, E G Atenafu, D H Kim, J Kuruvilla, J H Lipton, J Uhm, M Seftel, N Alam and V Gupta

Bone Marrow Transplant 2014 49: 1162-1169; advance online publication, June 30, 2014; 10.1038/bmt.2014.131

Abstract | Full Text

Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT

M A Kharfan-Dabaja, M Labopin, A Bazarbachi, R M Hamladji, D Blaise, G Socié, B Lioure, A Bermudez, L Lopez-Corral, R Or, W Arcese, N Fegueux, A Nagler and M Mohty

Bone Marrow Transplant 2014 49: 1170-1175; advance online publication, June 30, 2014; 10.1038/bmt.2014.133

Abstract | Full Text

HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1

K Fleischhauer, M A Fernandez-Viña, T Wang, M Haagenson, M Battiwalla, L A Baxter-Lowe, F Ciceri, J Dehn, J Gajewski, G A Hale, M B A Heemskerk, S R Marino, P L McCarthy, D Miklos, M Oudshoorn, M S Pollack, V Reddy, D Senitzer, B E Shaw, E K Waller, S J Lee and S R Spellman

Bone Marrow Transplant 2014 49: 1176-1183; advance online publication, June 23, 2014; 10.1038/bmt.2014.122

Abstract | Full Text

Donor–recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection

P B Dahi, D M Ponce, S Devlin, K L Evans, M Lubin, A M Gonzales, C Byam, M Sideroff, D Wells, S Giralt, N A Kernan, A Scaradavou and J N Barker

Bone Marrow Transplant 2014 49: 1184-1186; advance online publication, July 7, 2014; 10.1038/bmt.2014.135

Abstract | Full Text

Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT

S Fuji, J Kanda, S Kato, K Ikegame, S Morishima, T Miyamoto, M Hidaka, K Kubo, K Miyamura, K Ohashi, H Kobayashi, Y Maesako, S Adachi, T Ichinohe, Y Atsuta and Y Kanda on behalf of the HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation

Bone Marrow Transplant 2014 49: 1187-1192; advance online publication, July 7, 2014; 10.1038/bmt.2014.141

Abstract | Full Text

SUPPORTIVE CARE

Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa

G Milone, S Leotta, A Cupri, A L Fauci, P Spina, M Parisi, D Berritta and G Tripepi

Bone Marrow Transplant 2014 49: 1193-1197; advance online publication, July 7, 2014; 10.1038/bmt.2014.140

Abstract | Full Text

GRAFT-VERSUS-HOST DISEASE

Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD

W A Bethge, F R Kerbauy, E B Santos, T Gooley, R Storb and B M Sandmaier

Bone Marrow Transplant 2014 49: 1198-1204; advance online publication, July 21, 2014; 10.1038/bmt.2014.137

Abstract | Full Text

INFECTIONS

Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes

S Seo, H Xie, R A Karron, B Thumar, J A Englund, W M Leisenring, T Stevens-Ayers, M Boeckh and A P Campbell

Bone Marrow Transplant 2014 49: 1205-1211; advance online publication, June 30, 2014; 10.1038/bmt.2014.124

Abstract | Full Text

Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT

H J Park, M Park, M Han, B H Nam, K N Koh, H J Im, J W Lee, N-G Chung, B Cho, H-K Kim, K H Yoo, H H Koo, H J Kang, H Y Shin, H S Ahn, Y T Lim, H Kook, C J Lyu, J O Hah, J E Park, Y J Lim and J J Seo

Bone Marrow Transplant 2014 49: 1212-1216; advance online publication, July 7, 2014; 10.1038/bmt.2014.136

Abstract | Full Text

QOL AND PATIENTS' CARE

Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT

S Sarkar, A Scherwath, L Schirmer, F Schulz-Kindermann, K Neumann, M Kruse, A Dinkel, S Kunze, F Balck, N Kröger, U Koch and A Mehnert

Bone Marrow Transplant 2014 49: 1217-1222; advance online publication, July 7, 2014; 10.1038/bmt.2014.139

Abstract | Full Text

Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study

M Kirsch, A Götz, J P Halter, U Schanz, G Stussi, F Dobbels and S De Geest

Bone Marrow Transplant 2014 49: 1223-1230; advance online publication, July 21, 2014; 10.1038/bmt.2014.142

Abstract | Full Text

Letters To The Editor

Top

BEAM-conditioned autologous SCT improves the quality of response in Waldenström’s macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre’s 10-year experience

M A V Marzolini, K J Thomson, J Dorman and S D'Sa

Bone Marrow Transplant 2014 49: 1231-1232; advance online publication, June 2, 2014; 10.1038/bmt.2014.113

Full Text

Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis

E Kaul, G Shah, C Chaulagain and R L Comenzo

Bone Marrow Transplant 2014 49: 1233; advance online publication, June 16, 2014; 10.1038/bmt.2014.117

Full Text

Caregivers’ quality of life after blood and marrow transplantation: a qualitative study

H S L Jim, G P Quinn, A Barata, M Cases, J Cessna, B Gonzalez, L Gonzalez, A Koskan, F Montiel-Ishino and J Pidala

Bone Marrow Transplant 2014 49: 1234-1236; advance online publication, June 2, 2014; 10.1038/bmt.2014.118

Full Text

An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells?

S Bigliardi, M Morselli, L Potenza, P Bresciani, A Cuoghi, V Coluccio, G Riva, A Paolini, V Fantuzzi, L Faglioni, V Nasillo, A Messerotti, R Marasca, F Narni, M Luppi and F Forghieri

Bone Marrow Transplant 2014 49: 1237-1238; advance online publication, June 2, 2014; 10.1038/bmt.2014.119

Full Text

Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose

K B dos Santos, L J Costa, A Atalla, J Pereira and A E Hallack-Neto

Bone Marrow Transplant 2014 49: 1239-1240; advance online publication, June 2, 2014; 10.1038/bmt.2014.121

Full Text

Clinical impact of pre-transplant diastolic function on outcome after allogeneic hematopoietic SCT

N Shingai, K Kakihana, G Oshikawa, T Kobayashi, N Doki, H Sakamaki and K Ohashi

Bone Marrow Transplant 2014 49: 1241-1243; advance online publication, June 16, 2014; 10.1038/bmt.2014.126

Full Text

Juvenile arthritis after haematopoietic stem cell transplantation

E Tronconi, A Miniaci, A Prete, R Masetti and A Pession

Bone Marrow Transplant 2014 49: 1244-1245; advance online publication, June 2, 2014; 10.1038/bmt.2014.110

Full Text

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

L Castagna, R Crocchiolo, S Furst, J El-cheikh, B Esterni, A Granata, A Stoppa, R Boubdallah, D Coso, N Vey, A Charbonnier, C Lemarie, C Faucher, C Chabannon and D Blaise

Bone Marrow Transplant 2014 49: 1246-1247; advance online publication, July 7, 2014; 10.1038/bmt.2014.138

Full Text

Corrigendum

Top

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

L Castagna, R Crocchiolo, S Furst, J El-cheikh, B Esterni, A Granata, A Stoppa, R Boubdallah, D Coso, N Vey, A Charbonnier, C Lemarie, C Faucher, C Chabannon and D Blaise

Bone Marrow Transplant 2014 49: 1248; 10.1038/bmt.2014.191

Full Text

Advertisement
ICB is celebrating its 90th anniversary

Have you read these special features published in ICB this year? 

The Temporospatial Control of Tfh Cells

NK cell recognition of unconventional ligands 

Immunometabolism: The interface of immune and metabolic responses in disease
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: